{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:00:33Z","timestamp":1790805633167,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.xphs.2026.104439","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:40:17Z","timestamp":1785307217000},"page":"104439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A rapid strategy for domain-specific Fab glycosylation profiling of monoclonal antibodies via selective native deglycosylation and ultrafiltration"],"prefix":"10.1016","volume":"115","author":[{"given":"Yangguo","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhen","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7353-4826","authenticated-orcid":false,"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2026.104439_bib0001","series-title":"MAbs","first-page":"205","article-title":"Glycan analysis of therapeutic glycoproteins","author":"Zhang","year":"2016"},{"issue":"2","key":"10.1016\/j.xphs.2026.104439_bib0002","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1080\/07388551.2020.1869684","article-title":"Characterization of glycosylation in monoclonal antibodies and its importance in therapeutic antibody development","volume":"41","author":"Kaur","year":"2021","journal-title":"Crit Rev Biotechnol"},{"key":"10.1016\/j.xphs.2026.104439_bib0003","series-title":"MAbs","first-page":"699","article-title":"Correct primary structure assessment and extensive glyco-profiling of cetuximab by a combination of intact, middle-up, middle-down and bottom-up ESI and MALDI mass spectrometry techniques","author":"Ayoub","year":"2013"},{"issue":"3","key":"10.1016\/j.xphs.2026.104439_bib0004","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ejpb.2011.06.010","article-title":"Glycosylation profiles of therapeutic antibody pharmaceuticals","volume":"79","author":"Wacker","year":"2011","journal-title":"Eur J Pharm Biopharm"},{"key":"10.1016\/j.xphs.2026.104439_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1429600","article-title":"In silico evaluation of the role of Fab glycosylation in cetuximab Antibody dynamics","volume":"15","author":"Saporiti","year":"2024","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.xphs.2026.104439_bib0006","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4049\/jimmunol.1502136","article-title":"The emerging importance of IgG Fab glycosylation in immunity","volume":"196","author":"van de Bovenkamp","year":"2016","journal-title":"J Immunol"},{"issue":"47","key":"10.1016\/j.xphs.2026.104439_bib0007","doi-asserted-by":"crossref","first-page":"12023","DOI":"10.1073\/pnas.1812833115","article-title":"Site-selective chemoenzymatic glycoengineering of Fab and Fc glycans of a therapeutic antibody","volume":"115","author":"Giddens","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.xphs.2026.104439_bib0008","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ab.2005.11.012","article-title":"Impact of variable domain glycosylation on antibody clearance: an LC\/MS characterization","volume":"349","author":"Huang","year":"2006","journal-title":"Anal Biochem"},{"issue":"8","key":"10.1016\/j.xphs.2026.104439_bib0009","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1021\/jasms.4c00063","article-title":"Rapid mass spectrometry-based multiattribute method for glycation analysis with integrated afucosylation detection capability","volume":"35","author":"Xu","year":"2024","journal-title":"J Am Soc Mass Spectrom"},{"issue":"11","key":"10.1016\/j.xphs.2026.104439_bib0010","doi-asserted-by":"crossref","first-page":"3029","DOI":"10.1074\/mcp.M114.039537","article-title":"Immunoglobulin G (IgG) Fab glycosylation analysis using a new mass spectrometric high-throughput profiling method reveals pregnancy-associated changes","volume":"13","author":"Bondt","year":"2014","journal-title":"Mol Cell Proteom"},{"key":"10.1016\/j.xphs.2026.104439_bib0011","article-title":"Glycosylation engineering of biopharmaceuticals","volume":"988","author":"Beck","year":"2013","journal-title":"Methods Mol Biol"},{"issue":"6","key":"10.1016\/j.xphs.2026.104439_bib0012","doi-asserted-by":"crossref","first-page":"3562","DOI":"10.1021\/acs.analchem.6b04856","article-title":"Application of a quantitative LC\u2013MS multiattribute method for monitoring domain-specific glycan heterogeneity on a monoclonal antibody containing two N-linked glycosylation sites","volume":"89","author":"Wang","year":"2017","journal-title":"Anal Chem"},{"issue":"1-2","key":"10.1016\/j.xphs.2026.104439_bib0013","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jim.2012.05.022","article-title":"Quantitative glycan profiling of normal human plasma derived immunoglobulin and its fragments Fab and Fc","volume":"382","author":"Anumula","year":"2012","journal-title":"J Immunol Methods"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354926002881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:26:51Z","timestamp":1790803611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354926002881"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S0022354926002881"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104439","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rapid strategy for domain-specific Fab glycosylation profiling of monoclonal antibodies via selective native deglycosylation and ultrafiltration","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2026.104439","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Pharmacists Association\u00ae. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104439"}}